Point-of-care testing
8 articles
The New South Wales Dried Blood Spot Pilot
Testing, diagnosis, and treatment following the implementation of a program to provide dried blood spot testing for HIV and hepatitis C infections: the NSW DBS Pilot More
Point-of-Care Testing Increases HCV Treatment Uptake in Priority Settings in Australia
Among patients in 3 priority settings, the implementation of hepatitis C virus antibody and RNA point-of-care testing led to higher rates of testing, treatment uptake, and linkage to care. More
Community-Led Hepatitis Care Model in India: Same-Day HCV Treatment Initiation at Drug Treatment Centers
A community-led and comprehensive hepatitis care model, including same-day HCV treatment initiation at drug treatment centers, piloted in Manipur, India, proved to be feasible and effective. More
Danaher Continues to Charge Exorbitant Prices for Lifesaving Medical Tests Despite Urgent Demands for Price Reductions by Several Ministries of Health
Several Ministries of Health have written to Danaher requesting that the price of the tests for XDR-TB, HIV and hepatitis — currently priced at $14.90 per test cartridge — also be lowered to no more than $7.97. More
FDA Permits Marketing of First Point-of-Care Hepatitis C RNA Test
Test Enables Single-Visit Testing and Treatment for Hepatitis C. More
